Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Carter

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Monographs in Pathology|January 1, 1992
The biology of prostate cancer: new and future directions in predicting tumor behaviorA W Partin, H B Carter, J I Epstein, et al.
Analytical and Quantitative Cytology and Histology|October 1, 1990
Comparison of DNA ploidy and nuclear size, shape and chromatin irregularity in tissue sections and smears of prostatic carcinomaJ I Epstein, W N Christensen, G D Steinberg, et al.
The Journal of Urology|August 1, 1993
Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels?B M Ronnett, M J Carmichael, H B Carter, et al.
Urology|May 1, 1997
Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancerR Thiel, J D Pearson, J I Epstein, et al.
The Journal of Urology|February 1, 1986
Fine needle aspiration of the abnormal prostate: a cytohistological correlationH B Carter, R A Riehle, J H Koizumi, et al.
The Journal of Urology|November 1, 1990
The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancerH B Carter, A W Partin, J I Epstein, et al.
Urology|October 1, 1993
Relationship between changes in prostate-specific antigen and prognosis of prostate cancerJ A Cadeddu, J D Pearson, A W Partin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancerS M Harman, E J Metter, M R Blackman, et al.
Journal of the National Cancer Institute|October 21, 1999
Prostate-specific antigen testing of older menH B Carter, P K Landis, E J Metter, et al.
JAMA|May 14, 1997
Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancerH B Carter, J I Epstein, D W Chan, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Monographs in Pathology|January 1, 1992
The biology of prostate cancer: new and future directions in predicting tumor behaviorA W Partin, H B Carter, J I Epstein, et al.
Analytical and Quantitative Cytology and Histology|October 1, 1990
Comparison of DNA ploidy and nuclear size, shape and chromatin irregularity in tissue sections and smears of prostatic carcinomaJ I Epstein, W N Christensen, G D Steinberg, et al.
The Journal of Urology|August 1, 1993
Does high grade prostatic intraepithelial neoplasia result in elevated serum prostate specific antigen levels?B M Ronnett, M J Carmichael, H B Carter, et al.
Urology|May 1, 1997
Role of prostate-specific antigen velocity in prediction of final pathologic stage in men with localized prostate cancerR Thiel, J D Pearson, J I Epstein, et al.
The Journal of Urology|February 1, 1986
Fine needle aspiration of the abnormal prostate: a cytohistological correlationH B Carter, R A Riehle, J H Koizumi, et al.
The Journal of Urology|November 1, 1990
The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancerH B Carter, A W Partin, J I Epstein, et al.
Urology|October 1, 1993
Relationship between changes in prostate-specific antigen and prognosis of prostate cancerJ A Cadeddu, J D Pearson, A W Partin, et al.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancerS M Harman, E J Metter, M R Blackman, et al.
Journal of the National Cancer Institute|October 21, 1999
Prostate-specific antigen testing of older menH B Carter, P K Landis, E J Metter, et al.
JAMA|May 14, 1997
Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancerH B Carter, J I Epstein, D W Chan, et al.
Pageof 10